Related Experiment Video
Updated: May 28, 2026
10:23
Fabrication and Characterization of Colorectal Cancer Organoids from SW1222 Cell Line in Ultrashort Self-Assembling Peptide Matrix
Published on: May 3, 2024
Engineering pro-angiogenic peptides using stable, disulfide-rich cyclic scaffolds.
Lai Y Chan1, Sunithi Gunasekera, Sonia T Henriques
1Institute for Molecular Bioscience, The University of Queensland, Brisbane, QLD 4072, Australia.
Blood
|November 1, 2011
Summary
Small peptide fragments show promise for promoting blood vessel growth (angiogenesis). Grafting these fragments into cyclic peptide scaffolds significantly enhances their stability and therapeutic potential for angiogenesis applications.
Area of Science:
- Biochemistry
- Molecular Biology
- Biotechnology
Background:
- Linear peptides from extracellular matrix proteins (laminin, osteopontin) and VEGF exhibit proangiogenic activity.
- These small linear peptides (<10 residues) have poor stability, limiting their use as therapeutic drug candidates for angiogenesis.
Purpose of the Study:
- To improve the stability and therapeutic potential of proangiogenic peptide sequences.
- To investigate the use of cyclic peptide scaffolds for enhancing peptide drug properties.
Main Methods:
- Utilized naturally occurring plant-derived cyclic peptides, Momordica cochinchinensis trypsin inhibitor-II (MCoTI-II) and sunflower trypsin inhibitor-1 (SFTI-1), as scaffolds.
- Grafted small proangiogenic peptide fragments onto these cyclic peptide scaffolds.
- Assessed the stability of the designed peptides in human serum and their in vivo angiogenic activity.
Main Results:
- Designed peptides demonstrated significantly improved stability in human serum compared to linear fragments.
- The engineered peptide induced angiogenesis in vivo at nanomolar concentrations.
- This approach successfully enhanced both the activity and stability of angiogenic peptide sequences.
Conclusions:
- Grafting proangiogenic peptides onto cyclic peptide scaffolds (MCoTI-II, SFTI-1) is an effective strategy to enhance their stability and therapeutic efficacy.
- This method presents a promising avenue for developing novel therapeutic agents for promoting angiogenesis.
- The developed peptide is stable and potent, offering potential for clinical applications in regenerative medicine.
